Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06938542

Palliative Care Needs of Children With Rare Diseases and Their Families

The palliative care needs of family caregivers of children with rare diseases and their children are largely unmet, including the need for support to prepare for future medical decision making. This trial will test the FACE-Rare intervention to see if investigators can identify and meet those needs; and if FACE-Rare effects family caregivers' quality of life and child healthcare utilization. Finally, investigators will determine if the intersectionality of child-sex, family-race, Federal poverty level, and social connection influences family quality of life and child health care utilization longitudinally.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Conditions

Trisomy 13 Syndrome Abnormalities, Multiple Anxiety Disorders Arthrogryposis Congenita Multiplex With Intestinal Atresia Asparagine Synthetase Deficiency Behavior Behavioral Symptoms Beta-Propeller Protein-Associated Neurodegeneration Blindness Blood Coagulation Disorders Blood Coagulation Disorders, Inherited Bone Diseases Bone Diseases, Developmental Brain Injury of Prematurity With Periventricular Leukomalacia CHARGE Syndrome Cardiovascular Abnormalities Cardiovascular Diseases Chromosome 17p13.3 Microdeletion Syndrome Chromosome 1q43-1q44 Deletion Chromosome Disorders Coagulation Protein Disorders Cockayne Syndrome Coloboma Congenital Abnormalities Congenital Diaphragmatic Hernia Congenital, Hereditary, and Neonatal Diseases and Abnormalities Connective Tissue Diseases Craniofacial Abnormalities DNA Repair-Deficiency Disorders Deaf-Blind Disorders Deafness Depression Digestive System Diseases Disease Attributes Dwarfism Ear Diseases Early Infantile Epileptic Encephalopathy End-Stage Renal Disease With Cloacal Anomaly Eye Diseases Eye Diseases, Hereditary FOXG1 Syndrome Factor VII Deficiency Gastrointestinal Diseases Genetic Diseases, Inborn Hearing Disorders Hearing Loss Heart Defects, Congenital Heart Diseases Hematologic Diseases Hemic and Lymphatic Diseases Hemophilia A Hemorrhagic Disorders Heredodegenerative Disorders, Nervous System Hernia Hernia, Diaphragmatic Hernias, Diaphragmatic, Congenital Infantile Epileptic-Dyskinetic Encephalopathy Intellectual Disability Internal Hernia Intestinal Diseases KBG syndrome Malabsorption Syndromes Mental Disorders Metabolic Diseases Mitochondrial Depletion Disorder Musculoskeletal Abnormalities Musculoskeletal Diseases Nervous System Diseases Neurobehavioral Manifestations Neurodegenerative Diseases Neurologic Manifestations Noonan Syndrome Nutritional and Metabolic Diseases Otorhinolaryngologic Diseases Pathologic Processes Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Postoperative Complications Rare Diseases Sensation Disorders Severe Factor VII Deficiency Severe Hemophilia A Short Bowel Syndrome Signs and Symptoms Skin and Connective Tissue Diseases Vision Disorders

Age range

12 month–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Children's National Hospital

Washington D.C., District of Columbia, 20010, United States

About this study

Pediatric patients with rare diseases experience high mortality with 30% not living to see their 5th birthday. Families are likely to be asked to make complex medical decisions for their child. Pediatric advance care planning involves preparation and skill development to help make future medical care choices. Children with rare disorders are a heterogeneous group, resulting in their exclusion from research. Available research on families of children with rare diseases lacks scientific rigor. Although desperately needed, there are few empirically validated interventions to address these issues. Investigators propose to close a gap in our knowledge of families' needs for support in a heterogeneous group of children with rare diseases; and to test an advance care planning intervention. The FAmily CEntered (FACE) pediatric advance care planning intervention is adapted to families with children who have rare diseases. Theoretically informed and developed and adapted by the principal investigator and key stakeholders, the proposed intervention will use Respecting Choices Next Steps Pediatric ACP™ for families whose child is unable to participate in health care decision-making. Our consultation with families of children with rare disorders and the National Organization for Rare Disorders (NORD) revealed that basic palliative care needs should be addressed first, prior to an advance care planning intervention. For the study to be able to meet this request, all families randomized to the intervention will first complete the Carer Support Needs Assessment Tool (CSNAT)© adapted by investigators for use in pediatrics. In the CSNAT Approach, facilitators assess caregivers' prioritized palliative care needs and develop Shared Action Plans for increasing informal social support. Thus, investigators propose an innovative 3-session FACE-Rare intervention, integrating two evidence-based approaches. Investigators will evaluate FACE-Rare using a scientifically rigorous intent-to-treat, assessor-blinded, longitudinal, prospective, three-site, randomized controlled trial design. Family/child triads (N=160) will be randomized to FACE-Rare (CSNAT Sessions 1 & 2 plus Respecting Choices Sessions 3) or an enhanced information Treatment as Usual control group. All families will complete questionnaires at baseline and follow-up at 3-, 6- and 12 months. Investigators will evaluate the effect of FACE-Rare on family quality of life (caregiver appraisal, psychological, spiritual). Investigators will assess the palliative care needs of families at four time points. Investigators will determine the intersectionality of child-sex, family-race, and household income on family caregiver quality of life and child healthcare utilization. Investigators will explore the influence of urban vs. rural setting and religious coping on quality-of-life outcomes. Investigators will use advanced statistical methods informed by statistical advice from rare disease investigators for clinical trials in small populations.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Child inclusion criteria:

  • ≥1.0 years and <18.0 years at enrollment.
  • Unable to participate in end-of-life care decision-making.
  • Has a rare disease as operationally defined by NIH's Genetic and Rare Diseases Information Center (GARD).
  • Not under a Do Not Resuscitate Order or Allow a Natural Death Order.
  • Not in the Intensive Care Unit.

Family caregiver inclusion criteria:

  • > 18.0 years at enrollment.
  • Child's family caregiver/legal guardian.
  • Not known to be developmentally delayed.

Support person inclusion criteria:

  • > 18.0 years at enrollment.
  • Chosen by family caregiver.
  • Not known to be developmentally delayed.

Exclusion criteria

  • Family caregiver or support person is actively homicidal, suicidal, or psychotic at the time of enrollment.

Treatment and study plan

Family Centered pediatric palliative care for family caregivers of children with rare diseases.

Behavioral

Child with rare disease who is unable to participate in medical decision making/family caregiver/support person triads will be randomized at a 1:1 ratio to one of two study arms, either the 3 session FACE-Rare intervention or the enhanced Treatment as Usual. Assessments will be completed at baseline, 3, 6 and 12 month outcomes.

Primary outcomes

  1. Family Appraisal of Caregiving for Palliative Care (FACQ-PC)

    Time frame: Baseline, 3-, 6-, and 12 month post-intervention

    The FACQ-PC is a 25-item measure consists of four theoretically derived subscales: (i) caregiver strain, (ii) positive caregiving appraisals, (iii) caregiver distress, and (iv) family well-being. Scores are from 5 = strongly agree to 1 = strongly disagree. Investigators will not calculate a Total score. On the subscale scores for positive caregiving appraisals and family well-being, higher scores mean better outcomes, i.e. greater positive caregiving appraisals or family well-being. On the subscale scores for caregiver strain and caregiver distress, higher scores mean worse outcomes, i.e. greater caregiver strain or caregiver distress. The FACQ-PC subscale scores will be computed by taking the mean of the items (score range 1-5). Some items are reverse scored, depending on how the item is phrased, so that higher scores = higher amount of the subscale being measured. So the minimum value for each subscale is 1 and the maximum value for each subscale is 5.

  2. Functional Assessment of Chronic Illness Therapy-Spirituality-12 Version 4 Expanded (FACIT-Sp-EX)

    Time frame: Baseline, 3-, 6-, and 12 month post-intervention

    Assessed construct of spiritual well-being. Two subscales Meaning/Peace (7 items) and Faith (5 items) and Total score (12 items) were calculated. on a 5-point Likert scale from 0=not at all to 5=very much. Some items are reverse scored. See www.facit.org Meaning/Peace subscale score range from minimum value of 0 to maximum value of 32. Higher scores indicate better meaning/peace.

    Faith subscale score range from 0 minimum value to maximum value of 16. Higher scores indicate better meaning/peace.

    Total score range is from 0 minimum value to maximum value of 92. Higher scores indicate better spiritual well-being.

  3. Advance Care Plan for Child with Rare Disease Located in the Electronic Health Record (EHR).

    Time frame: Baseline and 1 year

    Documentation of an advance care plan for child with rare disease in the Electronic Health Record and decisional preference - to continue all treatments, to continue all treatments with exceptions noted, to provide comfort care only.

  4. Child Healthcare Utilization: initiation of palliative care consultations

    Time frame: Baseline, 3-, 6-, 12-month.

    Using a standardized data abstraction form to count initiation of palliative care consultations during the study.

  5. Generalized Anxiety Disorder-7 (GAD-7)

    Time frame: Baseline, 3-, 6-, 12-month

    Quality of life indicator with respect to emotional health-anxiety symptoms. 7 items. Higher scores indicate greater anxiety.

  6. Patient Health Questionaire-9 (PHQ-9)

    Time frame: Baseline, 3-, 6-, 12-month

    Quality of life indicator with respect to emotional health-depressive symptoms. 9 items. Higer scores indicate higher symptoms of depression. A yes response to question 9 (self-harm) will trigger a referral.

  7. Child Healthcare Utilization: # of days in palliative care before death.

    Time frame: Baseline, 3-, 6-, 12-month

    Using a standardized data abstraction form to count # of days in palliative care before death.

  8. Child Healthcare Utilization: # of hospitalizations during study participation

    Time frame: Baseline, 3-, 6-, 12-month

    Using a standardized data abstraction form to count # of days hospitalized during the study.

  9. Child Healthcare Utilization: # of Emergency Department visits during study participation

    Time frame: Baseline, 3-, 6-, 12-month

    Using a standardized data abstraction form to count # of days used Emergency Department during study.

  10. Child Healthcare Utilization: # of days in the Intensive Care Unit (ICU)

    Time frame: Baseline, 3-, 6-, 12-month

    Using a standardized data abstraction form to count # of days was admitted to ICU during the study.

  11. Child Healthcare Utilization: # of surgeries

    Time frame: Baseline, 3-, 6-, 12-month

    Using a standardized data abstraction form to count # of surgeries during the study.

Other outcomes

  1. Demographic Questionnaire

    Time frame: Baseline

    Age of family caregiver, support person, and child.

  2. Process Measure: Satisfaction Questionnaire

    Time frame: Week 4

    Study specific process measure to assess adverse events and benefit/burden of participation. 13 items. Higher scores indicate greater satisfaction. Items are on a 5-point Likert scale from strongly disagree to strongly agree. 6 items were negative (felt afraid, too much to handle, harmful, angry, sad, hurtful) and 7 items were positive (useful, helpful, load off my mind, satisfied, something I needed to do, courageous, worthwhile). Each subscale is scored separately. Higher score for positive scale was better outcome. Higher score for negative scale was worse outcome.

  3. Process Measure: Role Stress

    Time frame: Baseline, 3-, 6-, 12-month

    Visual analogue scale 0-100. "How stressful is it for you to make medical decisions for your child?" 1 item.

  4. Brief-Multidimensional Measure of Spirituality and Religion (Brief MMRS)

    Time frame: Baseline, 3-, 6-, 12-month

    Responses to 5 items from our previous research will be used to test moderator effects: "How often do you go to religious services? How often do you feel God's presence? how often do you pray privately? Do you identify as a religious person? Do you identify as a spiritual person?" Responses are on a 5 point likert scale. Higher scores indicated greater attendance at religious services, etc.

  5. BRICS (Brazil, Russia, India, China, South Africa) National Institute of Nursing Research (NINR) Social Determinants of Health (SDOH)

    Time frame: Baseline, 3-, 6-, 12-month

    NINR/National Institute of Health: "The SDOH are the conditions in which people are born, grow, live, work and age…." 32 items. Social connection score (how often, talk on telephone with family, friends, neighbors; get together; attend church or religious services; belong to clubs or organizations; marital partner status) and 2023 Federal Poverty Level for household income. Health insurance and housing insecurity will be used in secondary analysis.

  6. Health Resources and Services Administration (HRSA) Rural Health Grants Eligibility Analyzer

    Time frame: Baseline, 3-, 6-, 12-month

    Urban vs. rural setting. Address of participant is entered into the online analyzer, and it determines if this is a rural or urban setting which will be recorded in the data base.

  7. Carer Alert Thermometer (CAT)

    Time frame: Sessions 1 and 2 -- 2 and 3-4 weeks post baseline

    Measures child and family caregiver palliative care needs: The CAT is an evidence-based, comprehensive tool comprising 12 questions (broad areas of support need), used to identify two domains of unmet support needs, the current caring situation and the health and well-being of the caregiver. There is a traffic light scoring system so caregivers can rate their support need as green (low), amber (medium), and red (high) indicating level of need and potential risk each alert poses to the caregiving situation. Administered only to intervention participants.

  8. Demographic Questionnaire - Sex

    Time frame: Baseline.

    Sex of child, family caregiver and support person.

  9. Demographic Questionnaire - Race

    Time frame: Baseline.

    Race of child, family caregiver, and support person

  10. Demographic Questionnaire - Ethnicity

    Time frame: Baseline.

    Ethnicity of child, family caregiver, and support person.

  11. Demographic Questionnaire - Marital status.

    Time frame: Baseline.

    Marital status of family caregiver and support person.

  12. Demographic Questionnaire - Education.

    Time frame: Baseline.

    Education of family caregiver and support person.

  13. Demographic Questionnaire - Federal Poverty Level.

    Time frame: Baseline.

    Income above or below the 2025 Federal Poverty Level. Number of persons living in the household and household income will be collected to calculate these data.

Sponsors and collaborators

Lead sponsor

Children's National Research Institute

Other

Collaborators

  • Akron Children's Hospital
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • Stanford University

Registry information

Acronym: FACE-Rare

Important dates

Study start
2025
Primary completion
2029
Study completion
2029
First posted
Apr 22, 2025
Registry last updated
Jan 28, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.